Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease

The aim of this study is to evaluate the role of the glycoxidation product, Nε-(carboxymethyl)lysine (CML), on the metabolism of LDL which can give rise to increased risks of Coronary Artery Disease (CAD) in Type 2 Diabetes Mellitus (T2DM) patients. Polyclonal anti-CML antibodies, were used for mea...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed, K.A.A., Muniandy, S., Ismail, I.S.
Format: Article
Published: 2008
Subjects:
Online Access:http://eprints.um.edu.my/7221/
http://scialert.net/abstract/?doi=jms.2008.152.161
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.7221
record_format eprints
spelling my.um.eprints.72212013-12-11T07:17:12Z http://eprints.um.edu.my/7221/ Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease Ahmed, K.A.A. Muniandy, S. Ismail, I.S. R Medicine The aim of this study is to evaluate the role of the glycoxidation product, Nε-(carboxymethyl)lysine (CML), on the metabolism of LDL which can give rise to increased risks of Coronary Artery Disease (CAD) in Type 2 Diabetes Mellitus (T2DM) patients. Polyclonal anti-CML antibodies, were used for measurement of serum CML. CML concentrations were measured by competitive enzyme-linked immunosorbent assay (ELISA) in the serum of 81 T2DM patients with CAD, 86 T2DM without CAD and 104 healthy subjects. LDLs from the study groups were isolated and labeled with the fluorescence dye, 1, 1�-dioctadecyl-3, 3, 3�, 3�-tetramethylindo carbocyanine perchlorate (DiI). LDL from healthy subjects was subjected to oxidation and glycation. Receptor-mediated uptake of labeled native and modified-LDL was studied in human hepatocellular carcinoma (HepG2) cells. CML concentrations were significantly higher in T2DM with CAD patients than diabetic patients but without CAD (529.5±83.6 vs. 425.1±64.4 ng mL-1, p<0.001). The uptake of DiI-LDL from type 2 diabetes patients without CAD was significantly lower than that for LDL from diabetic patients without CAD or glycated-LDL in HepG2 cells. This study demonstrated that CML may be largely responsible for the defective uptake of LDL of T2DM with CAD. Thus, CML may be used as endogenous biomarker for early detection of CAD in type 2 diabetes patients and may be considered as a new goal for the glycemic control in those patients. 2008 Article PeerReviewed Ahmed, K.A.A. and Muniandy, S. and Ismail, I.S. (2008) Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease. Journal of Medical Sciences, 8 (2). pp. 152-161. ISSN 1682-4474 http://scialert.net/abstract/?doi=jms.2008.152.161 10.3923/jms.2008.152.161
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic R Medicine
spellingShingle R Medicine
Ahmed, K.A.A.
Muniandy, S.
Ismail, I.S.
Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
description The aim of this study is to evaluate the role of the glycoxidation product, Nε-(carboxymethyl)lysine (CML), on the metabolism of LDL which can give rise to increased risks of Coronary Artery Disease (CAD) in Type 2 Diabetes Mellitus (T2DM) patients. Polyclonal anti-CML antibodies, were used for measurement of serum CML. CML concentrations were measured by competitive enzyme-linked immunosorbent assay (ELISA) in the serum of 81 T2DM patients with CAD, 86 T2DM without CAD and 104 healthy subjects. LDLs from the study groups were isolated and labeled with the fluorescence dye, 1, 1�-dioctadecyl-3, 3, 3�, 3�-tetramethylindo carbocyanine perchlorate (DiI). LDL from healthy subjects was subjected to oxidation and glycation. Receptor-mediated uptake of labeled native and modified-LDL was studied in human hepatocellular carcinoma (HepG2) cells. CML concentrations were significantly higher in T2DM with CAD patients than diabetic patients but without CAD (529.5±83.6 vs. 425.1±64.4 ng mL-1, p<0.001). The uptake of DiI-LDL from type 2 diabetes patients without CAD was significantly lower than that for LDL from diabetic patients without CAD or glycated-LDL in HepG2 cells. This study demonstrated that CML may be largely responsible for the defective uptake of LDL of T2DM with CAD. Thus, CML may be used as endogenous biomarker for early detection of CAD in type 2 diabetes patients and may be considered as a new goal for the glycemic control in those patients.
format Article
author Ahmed, K.A.A.
Muniandy, S.
Ismail, I.S.
author_facet Ahmed, K.A.A.
Muniandy, S.
Ismail, I.S.
author_sort Ahmed, K.A.A.
title Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
title_short Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
title_full Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
title_fullStr Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
title_full_unstemmed Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
title_sort implications of nîµ-(carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
publishDate 2008
url http://eprints.um.edu.my/7221/
http://scialert.net/abstract/?doi=jms.2008.152.161
_version_ 1643687993254346752
score 13.211869